Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Macmillan

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|July 31, 2015
Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2Thomas H Scheuermann, Daniel Stroud, Christopher E Sleet, et al.
Journal of Medicinal Chemistry|February 1, 2013
Development of inhibitors of the PAS-B domain of the HIF-2α transcription factorJamie L Rogers, Liela Bayeh, Thomas H Scheuermann, et al.
Scientific Reports|March 2, 2018
A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cellsBinita Das, Beth K Neilsen, Kurt W Fisher, et al.
The Journal of Biological Chemistry|March 18, 2016
Metabolite Regulation of Nuclear Localization of Carbohydrate-response Element-binding Protein (ChREBP): ROLE OF AMP AS AN ALLOSTERIC INHIBITORShogo Sato, Hunmin Jung, Tsutomu Nakagawa, et al.
Cell Chemical Biology|August 6, 2019
A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action DiscoveryElizabeth A McMillan, Gino Kwon, Jean R Clemenceau, et al.
Nature Communications|May 23, 2018
Author Correction: Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespanChensu Wang, Hanspeter Niederstrasser, Peter M Douglas, et al.
Nature Communications|December 24, 2017
Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespanChensu Wang, Hanspeter Niederstrasser, Peter M Douglas, et al.
Cancer Research|September 7, 2018
HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic StressBrandt A Nichols, Nathaniel W Oswald, Elizabeth A McMillan, et al.
Science Signaling|October 17, 2013
Using functional signature ontology (FUSION) to identify mechanisms of action for natural productsMalia B Potts, Hyun Seok Kim, Kurt W Fisher, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2022
High-throughput functional annotation of natural products by integrated activity profilingSuzie K Hight, Trevor N Clark, Kenji L Kurita, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|July 31, 2015
Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2Thomas H Scheuermann, Daniel Stroud, Christopher E Sleet, et al.
Journal of Medicinal Chemistry|February 1, 2013
Development of inhibitors of the PAS-B domain of the HIF-2α transcription factorJamie L Rogers, Liela Bayeh, Thomas H Scheuermann, et al.
Scientific Reports|March 2, 2018
A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cellsBinita Das, Beth K Neilsen, Kurt W Fisher, et al.
The Journal of Biological Chemistry|March 18, 2016
Metabolite Regulation of Nuclear Localization of Carbohydrate-response Element-binding Protein (ChREBP): ROLE OF AMP AS AN ALLOSTERIC INHIBITORShogo Sato, Hunmin Jung, Tsutomu Nakagawa, et al.
Cell Chemical Biology|August 6, 2019
A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action DiscoveryElizabeth A McMillan, Gino Kwon, Jean R Clemenceau, et al.
Nature Communications|May 23, 2018
Author Correction: Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespanChensu Wang, Hanspeter Niederstrasser, Peter M Douglas, et al.
Nature Communications|December 24, 2017
Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespanChensu Wang, Hanspeter Niederstrasser, Peter M Douglas, et al.
Cancer Research|September 7, 2018
HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic StressBrandt A Nichols, Nathaniel W Oswald, Elizabeth A McMillan, et al.
Science Signaling|October 17, 2013
Using functional signature ontology (FUSION) to identify mechanisms of action for natural productsMalia B Potts, Hyun Seok Kim, Kurt W Fisher, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2022
High-throughput functional annotation of natural products by integrated activity profilingSuzie K Hight, Trevor N Clark, Kenji L Kurita, et al.
Pageof 8